Meridian Clinical Research

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)3 trials

Phase

• Phase 33 trials

Status

• Completed3 trials

Lead sponsor

• Incyte Corporation2 trials
• Eli Lilly and Company1 trial

Closed trials

• Completed

  Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis

  NCT05456529· Phase 3· Incyte Corporation· Source

• Completed

  A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)

  NCT04921969· Phase 3· Incyte Corporation· Source

• Completed

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· Phase 3· Eli Lilly and Company· Source